Drugs / Pranoprofen

Trials 3 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 42 trials
Phase 4 NCT07291089 Feb 2024 → Nov 2025 cataract 50 with or without glaucoma, senile cataract Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Completed No outcome recorded
Phase 4 NCT03355638 Jan → Jul 2016 macular retinal edema University of Brescia Completed No outcome recorded
Phase not applicable1 trial
NCT03712670 Jan → Dec 2016 retinal disorder University of Brescia Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05771194 Background Feb 2021 → Mar 2022 eyelid disorder Tianjin Medical University Eye Hospital Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Pranoprofen pranoprofen (Qian Su Pharmaceutical Co., Ltd., Japan) was administered 4 times daily” NCT05771194
3

NCT03355638

NCT07291089

NCT03712670

Known as Elicapric ChEMBL registry synonym — accepted as the source's own label CHEMBL367463
Known as NSC-759832 ChEMBL registry synonym — accepted as the source's own label CHEMBL367463
Known as Pranoflog “Patients were given a bottle of eyedrops for self-administration of 0.1% pranoprofen (Pranoflog, Sifi SpA, Aci Sant'Antonio, CT, Italy).” NCT03355638
Known as Pranoprofene ChEMBL registry synonym — accepted as the source's own label CHEMBL367463
Known as Pranoprofeno ChEMBL registry synonym — accepted as the source's own label CHEMBL367463
Known as Pyranoprofen ChEMBL registry synonym — accepted as the source's own label CHEMBL367463
Modality Small molecule CHEMBL367463
Route Topical “0.1% pranoprofen 3 times a day topical eye drops administration” NCT03712670